Microrna-144 Expression Overcomes Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells by Targeting Survivin

Ki Eun Hwang; Eun-Taik Jeong; Hak-Ryul Kim

doi:10.1016/j.chest.2016.08.809

Microrna-144 Expression Overcomes Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells by Targeting Survivin

CHEST Journal ◽

10.1016/j.chest.2016.08.809 ◽

2016 ◽

Vol 150 (4) ◽

pp. 714A

Author(s):

Ki Eun Hwang ◽

Eun-Taik Jeong ◽

Hak-Ryul Kim

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Download Full-text

The Effect of Acquired Cisplatin Resistance on Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504012x13285365944337 ◽

2011 ◽

Vol 19 (10) ◽

pp. 471-478 ◽

Cited By ~ 3

Author(s):

Jin Kyung Rho ◽

Yun Jung Choi ◽

You Ri Choi ◽

Sun Ye Kim ◽

Su Jin Choi ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Cisplatin Resistance ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Download Full-text

Abstract 122: Stromal extracellular matrix is a microenvironmental cue promoting resistance to EGFR tyrosine kinase inhibitors in lung cancer cells

10.1158/1538-7445.am2019-122 ◽

2019 ◽

Author(s):

Ting Zhang ◽

Lixia Guo ◽

Yuanyuan Wang ◽

Tao Ren ◽

Yanan Yang

Keyword(s):

Lung Cancer ◽

Extracellular Matrix ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Abstract LB-126: PPARgamma agonists sensitize PTEN-deficient lung cancer cells resistant to EGFR tyrosine kinase inhibitors

10.1158/1538-7445.am2017-lb-126 ◽

2017 ◽

Author(s):

Kenneth KW To ◽

Wing Sum Tong ◽

William KK Wu ◽

Herbert HF Loong

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells

PLoS ONE ◽

10.1371/journal.pone.0041017 ◽

2012 ◽

Vol 7 (7) ◽

pp. e41017 ◽

Cited By ~ 37

Author(s):

Keisuke Tabara ◽

Rina Kanda ◽

Kahori Sonoda ◽

Takuya Kubo ◽

Yuichi Murakami ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Mutant Gene ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Download Full-text

Stromal extracellular matrix is a microenvironmental cue promoting resistance to EGFR tyrosine kinase inhibitors in lung cancer cells

The International Journal of Biochemistry & Cell Biology ◽

10.1016/j.biocel.2018.11.001 ◽

2019 ◽

Vol 106 ◽

pp. 96-106 ◽

Cited By ~ 4

Author(s):

Yuanyuan Wang ◽

Ting Zhang ◽

Lixia Guo ◽

Tao Ren ◽

Yanan Yang

Keyword(s):

Lung Cancer ◽

Extracellular Matrix ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

969 Antitumor Activity of NPS-1034, a Synthetic MET and AXL Inhibitor, in Lung Cancer Cells With Resistance to EGFR Tyrosine Kinase Inhibitors by MET or AXL Activation

European Journal of Cancer ◽

10.1016/s0959-8049(12)71587-3 ◽

2012 ◽

Vol 48 ◽

pp. S233

Author(s):

Y Park ◽

C.M. Choi ◽

J.C. Lee ◽

H.R. Kim

Keyword(s):

Lung Cancer ◽

Antitumor Activity ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Abstract 122: Stromal extracellular matrix is a microenvironmental cue promoting resistance to EGFR tyrosine kinase inhibitors in lung cancer cells

10.1158/1538-7445.sabcs18-122 ◽

2019 ◽

Author(s):

Ting Zhang ◽

Lixia Guo ◽

Yuanyuan Wang ◽

Tao Ren ◽

Yanan Yang

Keyword(s):

Lung Cancer ◽

Extracellular Matrix ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy

European Journal of Pharmacology ◽

10.1016/j.ejphar.2018.01.036 ◽

2018 ◽

Vol 823 ◽

pp. 19-26 ◽

Cited By ~ 10

Author(s):

Kenneth K.W. To ◽

William K.K. Wu ◽

Herbert H.F. Loong

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lung Cancer Cells ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or Gefitinib

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-1080 ◽

2011 ◽

Vol 17 (19) ◽

pp. 6322-6328 ◽

Cited By ~ 33

Author(s):

Geoffrey R. Oxnard ◽

Yelena Y. Janjigian ◽

Maria E. Arcila ◽

Camelia S. Sima ◽

Samantha L. Kass ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Download Full-text

Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line

Frontiers in Medicine ◽

10.3389/fmed.2016.00076 ◽

2017 ◽

Vol 3 ◽

Cited By ~ 20

Author(s):

Ivana Sullivan ◽

David Planchard

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Next Generation ◽

First Line ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Download Full-text